• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » GE Healthcare debuts breast cancer tech

GE Healthcare debuts breast cancer tech

October 20, 2020 By Sean Whooley

GE-Healthcare-logoGE Healthcare (NYSE:GE) announced today that it made the Serena Bright biopsy technology available in the U.S.

Chicago-based GE Healthcare touts Serena Bright as the industry’s first contrast-enhanced guided biopsy solution, according to a news release. The technology is designed to help clinicians and patients in the fight against breast cancer.

Serena Bright received FDA 510(k) clearance in June as a platform for conducting breast biopsy exams with contrast guidance using the same mammography equipment in the same room and with the same staff as the screening or diagnostic mammogram.

The system is also intended to help with delays in diagnoses due to the backlog of screenings because of the COVID-19 pandemic. GE Healthcare said it could allow for follow-up biopsy procedures to be done in a matter of days instead of over several weeks, as can be the case with MRI biopsy.

GE Healthcare’s system includes SenoBright HD CESM, a diagnostic breast exam with iodine-based contrast that offers high sensitivity for more accurate breast cancer diagnosis. It also highlights areas of unusual blood flow to localize lesions that need to be biopsied, which creates better image quality to help with clinical confidence.

“Now more than ever, it is critical we put the comfort of patients first and get them answers as fast as possible,” GE Healthcare president & CEO of women’s health & X-ray Agnes Berzsenyi said in the release. “We are proud to bring Serena Bright to our customers during a time when this type of innovation is needed most. We hope this technology can help improve breast cancer outcomes for women during this time of uncertainty.”

Jefferson Health in Philadelphia became the first healthcare system in the U.S. to offer this technology, while the company said healthcare providers around the world are now looking to implement the platform.

Filed Under: Business/Financial News, Featured, Imaging, Mammography, Oncology, Women's Health Tagged With: GE Healthcare

More recent news

  • Medtronic earns CE mark for redo TAVI procedure
  • Natus Neuro launches BrainWatch AI-driven, point-of-care EEG
  • Boston Scientific has positive real-world Acurate Prime TAVI data
  • Johnson & Johnson MedTech launches ultrasound catheter for imaging in cardiac ablation procedures
  • Onward reports more successful BCI implants

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy